BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs7903146
,
SIRT1
,
Response to oxidative stress
,
Lung cancer
,
Retina
,
Fluoxetine
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
RPA1 genes
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (1 of 2)
Gene expression profiling of smaug mutant embryos
Wildtype and smaug mutant embryos relative to mature stage 14 oocytes
B cell lymphoma cell line overexpressing tRNA-derived microRNA CU1276
Explore Curated Studies Results
Literature
Most Relevant Literature
RP2 X-LINKED RETINITIS PIGMENTOSA CARRIER STATE PRESENTING WITH VASCULAR LEAKAGE AND UNILATERAL MACU…
RP2-Associated X-linked Retinopathy: Clinical Findings, Molecular Genetics, and Natural History.
Profiling of visual acuity and genotype correlations in RP2 patients: a cross-sectional comparative …
Genotypic and phenotypic characterisation of RP2- and RPGR-associated X-linked inherited retinal dys…
Modeling and Rescue of RP2 Retinitis Pigmentosa Using iPSC-Derived Retinal Organoids.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung …
Olaparib Monotherapy in Relapsed Small Cell Lung Cancer Patients With HR Pathway Gene Mutations Not …
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific A…
A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001…
A Study of Niraparib in People With Soft Tissue Sarcoma Who Have Changes in Their Tumor DNA
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ